Close

Retrophin (RTRX) PT Raised to $32 at Leerink Partners Following Clear Efficacy from Sparsentan

Go back to Retrophin (RTRX) PT Raised to $32 at Leerink Partners Following Clear Efficacy from Sparsentan
RETROPHIN (NASDAQ: RTRX) Delayed: 24.25 --0 (-0%)
Previous Close $24.25    52 Week High $24.57 
Open $4.35    52 Week Low $11.60 
Day High $24.25    P/E N/A 
Day Low $24.25    EPS $-4.30 
Volume 217,426